Pipeline

An Innovation-Driven Company

Our rich pipeline of products, with seven approved NDAs in just seven years, demonstrates our leadership in developing technology-based drugs. Backed by decades of experience, we are able to streamline clinical development time and substantially increase the probability of late-stage product success.


Branded Pipeline Program Indication Commercial Partner Approval
  • Pre-Clinical
  • Early
    Clinical
  • Advanced
    Clinical
  • NDA
    Submission
  • Approval
TRN-124 Cough & Cold Vernalis
 
TRN-125 Cough & Cold Vernalis
 
TRN-110 ADHD in Pediatrics & Adults Tris
 
TRN-123 Cough & Cold Vernalis
 
TRN-112 Cough & Cold Vernalis
 
TRN-148 Pediatric CNS Tris
 
TRN-146 Pediatric CNS Undisclosed
 
TRN-105 Pain Tris
 
TRN-132 Pain Tris
 
TRN-133 Urology Tris
 
TRN-134 Sleep Disorder CNS Tris
 
TRN-135 Pediatric CNS Tris
 
Branded Pipeline Program: TRN-124
Indication: Cough & Cold
Commercial Partner: Vernalis
Approval: NDA Submission
Branded Pipeline Program: TRN-125
Indication: Cough & Cold
Commercial Partner: Vernalis
Approval: NDA Submission
Branded Pipeline Program: TRN-110
Indication: ADHD in Pediatrics & Adults
Commercial Partner: Tris
Approval: Advanced Clinical
Branded Pipeline Program: TRN-123
Indication: Cough & Cold
Commercial Partner: Vernalis
Approval: Early Clinical
Branded Pipeline Program: TRN-112
Indication: Cough & Cold
Commercial Partner: Vernalis
Approval: Early Clinical
Branded Pipeline Program: TRN-148
Indication: Pediatric CNS
Commercial Partner: Tris
Approval: Early Clinical
Branded Pipeline Program: TRN-146
Indication: Pediatric CNS
Commercial Partner: Undisclosed
Approval: Early Clinical
Branded Pipeline Program: TRN-105
Indication: Pain
Commercial Partner: Tris
Approval: Early Clinical
Branded Pipeline Program: TRN-132
Indication: Pain
Commercial Partner: Tris
Approval: Early Clinical
Branded Pipeline Program: TRN-133
Indication: Urology
Commercial Partner: Tris
Approval: Pre-Clinical
Branded Pipeline Program: TRN-134
Indication: Sleep Disorder CNS
Commercial Partner: Tris
Approval: Early Clinical
Branded Pipeline Program: TRN-135
Indication: Pediatric CNS
Commercial Partner: Tris
Approval: Pre-Clinical